ABVC BioPharma (ABVC) Short Interest Ratio & Short Volume → America’s worst nightmare? (From Porter & Company) (Ad) Free ABVC Stock Alerts $1.08 +0.01 (+0.93%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media ABVC BioPharma Short Interest DataCurrent Short Volume637,600 sharesPrevious Short Volume533,000 sharesChange Vs. Previous Month+19.62%Dollar Volume Sold Short$797,000.00Short Interest Ratio / Days to Cover0.6Last Record DateApril 30, 2024Outstanding Shares10,560,000 sharesFloat Size8,680,000 sharesShort Percent of Float7.35%Today's Trading Volume242,038 sharesAverage Trading Volume1,920,932 sharesToday's Volume Vs. Average13% Short Selling ABVC BioPharma ? Sign up to receive the latest short interest report for ABVC BioPharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatABVC Short Interest Over TimeABVC Days to Cover Over TimeABVC Percentage of Float Shorted Over Time Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. ABVC BioPharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024637,600 shares $797,000.00 +19.6%7.4%0.6 $1.25 4/15/2024533,000 shares $580,970.00 -59.6%6.1%0.6 $1.09 3/31/20241,320,000 shares $1.73 million +1,146.5%15.2%1.9 $1.31 3/15/2024105,900 shares $123,903.00 -30.0%1.3%0 $1.17 2/29/2024151,300 shares $183,073.00 +25.4%2.3%0.1 $1.21 2/15/2024120,700 shares $154,496.00 -2.7%1.8%0.1 $1.28 Get the Latest News and Ratings for ABVC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ABVC BioPharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024124,000 shares $188,480.00 -6.3%2.0%0.1 $1.52 1/15/2024132,400 shares $189,332.00 +717.3%1.9%0 $1.43 12/31/202316,200 shares $18,792.00 -65.5%0.3%0 $1.16 12/15/202346,900 shares $60,970.00 -58.8%0.8%0 $1.30 11/30/2023113,800 shares $143,388.00 +29.8%2.7%0 $1.26 11/15/202387,700 shares $109,625.00 -91.1%2.1%0 $1.25 10/31/2023984,400 shares $1.06 million +2,761.6%43.2%0.6 $1.08 10/15/202334,400 shares $32,336.00 +144.0%1.5%0 $0.94 9/30/202314,100 shares $14,664.00 -26.9%0.6%0 $1.04 9/15/202319,300 shares $20,265.00 -2.5%0.9%0 $1.05 8/31/202319,800 shares $25,938.00 -29.8%1.0%0 $1.31 8/15/202328,200 shares $53,862.00 -84.0%1.5%0 $1.91 7/30/2021100 shares $494.00 No ChangeN/A0.1 $4.94 4/30/2021500 shares $2,225.00 +400.0%N/A0.1 $4.45 4/15/2021100 shares $440.00 No ChangeN/A0 $4.40 3/31/2021100 shares $445.00 No ChangeN/A0.1 $4.45 3/15/2021100 shares $450.00 No ChangeN/A0.1 $4.50 12/31/2020400 shares $2,000.00 No ChangeN/A0.1 $5.00 11/30/2020500 shares $2,100.00 +400.0%N/A0.2 $4.20 11/15/2020100 shares $395.00 No ChangeN/A0 $3.95 9/15/2020100 shares $380.00 No ChangeN/A0.1 $3.80 8/31/2020100 shares $400.00 No ChangeN/A0.1 $4.00 8/14/2020100 shares $395.00 No ChangeN/A0.1 $3.95 7/31/2020100 shares $395.00 No ChangeN/A0 $3.95 7/15/2020100 shares $300.00 No ChangeN/A0.1 $3.00 6/30/2020100 shares $300.00 No ChangeN/A0 $3.00 6/15/2020100 shares $295.00 -66.7%N/A0.1 $2.95 5/29/2020300 shares $900.00 No ChangeN/A0.2 $3.00 5/15/2020300 shares $900.00 +200.0%N/A1 $3.00 4/30/2020100 shares $320.00 No ChangeN/A0.2 $3.20 4/15/2020100 shares $275.00 No ChangeN/A0.3 $2.75 3/31/2020100 shares $245.00 -93.3%N/A0.2 $2.45 3/13/20201,500 shares $4,350.00 +36.4%N/A0.6 $2.90 2/28/20201,100 shares $3,190.00 -21.4%N/A0.1 $2.90With revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (Ad)Revolutionizing communication is what this NASDAQ-traded next-gen solution provider is doing. See how this company is well-positioned to capitalize in 2024 ABVC Short Interest - Frequently Asked Questions What is ABVC BioPharma's current short interest? Short interest is the volume of ABVC BioPharma shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 637,600 shares of ABVC short. 7.35% of ABVC BioPharma's shares are currently sold short. Learn More on ABVC BioPharma's current short interest. What is a good short interest ratio for ABVC BioPharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABVC shares currently have a short interest ratio of 1.0. Learn More on ABVC BioPharma's short interest ratio. What is a good short interest percentage for ABVC BioPharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.35% of ABVC BioPharma's floating shares are currently sold short. Is ABVC BioPharma's short interest increasing or decreasing? ABVC BioPharma saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 637,600 shares, an increase of 19.6% from the previous total of 533,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ABVC BioPharma's float size? ABVC BioPharma currently has issued a total of 10,560,000 shares. Some of ABVC BioPharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ABVC BioPharma currently has a public float of 8,680,000 shares. How does ABVC BioPharma's short interest compare to its competitors? 7.35% of ABVC BioPharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ABVC BioPharma: Elevai Labs, Inc. (0.48%), Akari Therapeutics, Plc (0.03%), Eterna Therapeutics Inc. (1.15%), Avalo Therapeutics, Inc. (10.13%), MIRA Pharmaceuticals, Inc. (0.42%), Moleculin Biotech, Inc. (1.45%), Molecular Templates, Inc. (4.68%), Kiora Pharmaceuticals, Inc. (0.56%), Guardion Health Sciences, Inc. (14.33%), Monopar Therapeutics Inc. (1.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short ABVC BioPharma stock? Short selling ABVC is an investing strategy that aims to generate trading profit from ABVC BioPharma as its price is falling. ABVC shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ABVC BioPharma? A short squeeze for ABVC BioPharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABVC, which in turn drives the price of the stock up even further. How often is ABVC BioPharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABVC, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ELAB Short Interest AKTX Short Interest ERNA Short Interest AVTX Short Interest MIRA Short Interest MBRX Short Interest MTEM Short Interest KPRX Short Interest GHSI Short Interest MNPR Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ABVC) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityThe A.I. story nobody is telling you (Read ASAP)TradeSmithBuy this small stock before coming AI Tidal WaveChaikin AnalyticsRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap Sniper